netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Mapping the Circuits of the Retina

RPB Career Development Award recipient Gregory W. Schwartz, PhD, Northwestern University Feinberg School of Medicine has published a finding that opens the door to improving retinal prosthetic devices, targeting treatments to restore damaged retinal circuits, and improving early detection of retinal diseases.

And that's just the tip of the iceberg. "More generally, our work will provide a template for brain mapping efforts throughout the nervous system," says Schwartz.


Video, courtesy Northwestern University Feinberg School of Medicine, produced by Sarah Plumridge.

By employing a combination of established and novel techniques to measure connectivity and function in retinal neural circuits, Dr. Schwartz has made detailed circuit models to predict the response of the target cell to various visual stimuli. As part of his team's work, they have discovered many new retinal ganglion cell (RGC) types, for which they are seeking to identify unique genetic markers.

"Dr. Schwartz is a uniquely talented computational neuroscientist who has very novel ideas concerning the circuitry of the retina," said Nicholas J. Volpe, MD, Chairman, Department of Ophthalmology, Northwestern University Feinberg School of Medicine. "I believe this work will set a new standard for our understanding of how information is processed in the retina. The retinal circuitry maps that Dr. Schwartz produces will greatly facilitate our national mandate for brain mapping efforts throughout the central nervous system."

"RPB is extremely pleased that our Career Development Award to Dr. Schwartz helped him lay the groundwork for his recent, prestigious, five-year, $2.3 million grant from the National Institutes of Health to continue this important work," adds RPB President Brian F. Hofland, PhD. "This is precisely the kind of outcome we envisioned in establishing this grant."

Visit the Schwartz lab.

Read the full story.

Read the study.

Read more about RPB Grants.

Related News: Artificial Vision, Feature Story, Neuro-Ophthalmology, Retina Disorders , Top Story

EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS

(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.

Read More

 

RESEARCH TO PREVENT BLINDNESS AND LIONS CLUBS INTERNATIONAL FOUNDATION TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP

Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.

Read More

 

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.